Option 3
Option 3 is a medical device development and commercialization vehicle formed by Research Corporation Technoliogies and James Dreher to invest in the development and commercialization of select medical device products that are not technically complex, capital intensive to develop or require significant clinical data to be approved and marketed.
Option 3’s first investment is in Axiom Technology Partners, LLC, a company formed in 2010 to develop and commercialize a novel fascial closure device called the Weck EFx Endo Fascial Closure System. Learn more about it at TeleFlex.com.
RCT Contact
Related News & Events
- 7.17.2019: Q’Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter
- 10.29.2015: TELEFLEX ACQUIRES OPTION3’s ATSINA SURGICAL IN ALL-CASH TRANSACTION…
- 8.28.2012: Option 3’s Laproscopic Fascial Closure System Awarded Innovation of the Year
- 5.1.2012: Teleflex Acquires Option 3’s Laparoscopic Fascial Closure System